"Think big" or buying new instruments are not enough in order to reduce cost of goods, increasing efficacy, safety, and quality of biomanufacturing. Klaus Kaiser discusses why mammalian cell culture manufacturing is not yet fully exploited and what could be done.

For accessing this article, please click on your left "Subscription". Thank you.